Skip to main content

Table 1 Demographic data of pediatric cases who had undergone liver and kidney transplantation (N = 51)

From: Pediatric liver and kidney transplantation in the era of COVID-19: a follow-up study from a tertiary referral center in Iran

Variable Total (N or Mean ± SD) Kidney Tx recipients (n = 11) Liver Tx recipients (n = 40)
Age (years) 6.72 ± 5.47 7.72 ± 4.91 6.11 ± 5.80
Sex
 Male 33 (64.7) 4 29
 Female 18 (35.3) 7 11
White blood cells 8.79 ± 5.57 9.01 ± 6.77 8.66 ± 5.32
Creatinine (mg/dL) 0.64 ± 1.04 0.80 ± 1.00 0.61 ± 0.95
Aspartate transaminase (U/L) 161.58 ± 132.52 21.39 ± 19.88 171.21 ± 134.01
Alanine aminotransferase (U/L) 98.75 ± 80.93 14.33 ± 10.00 112.67 ± 99.07
Total Bilirubin (mg/dL) 17.96 ± 16.88 1.22 ± 1.00 19.08 ± 17.23
PELD score 21.20 ± 8.88 21.20 ± 8.88
Patients outcome
 Alive 40 (78.4) 11 29
 Expired 11 (21.6) 0 11
Immunosuppressive regimen
 Tacrolimus + prednisolone 32(62.74%) 1 31
 Mycophenolate mofetil + tacrolimus 9 (17.64%) 1 8
 Cyclosporine + prednisolone 10(19.60%) 9 1
Induction regimen
Methylprednisolone 41(80.39%) 8 33
Thymoglobulin 10 (19.6%) 3 7
Post-transplant laboratory value
O2 saturation (%) 91 93 90
 Lymphocytopenia 5 (10.6%) 2 3
 Lymphocytosis 13 (27.7%) 1 12
 Elevated CRP 19 (51.4%) 10 9
 Elevated ESR 8 (22.9%) 3 5
 Prograf level(ng/dl) 4.91 ± 2.21 5.82 ± 1.99 4.88 ± 2.01
 Cyclosporine level 190.34 ± 34.12 194.00 ± 36.21 188.30 ± 30.01
 CMV PCR positive 4 (14.8%) 3 1
  1. Tx, transplant; PELD, Pediatric end-stage liver disease; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; CMV, cytomegalovirus; PCR, polymerase chain reaction